Chorionic somatomammotropin impacts early fetal growth and placental gene expression.
Chorionic somatomammotropin impacts early fetal growth and placental gene expression.
复制标题
DOI:
10.1530/joe-18-0093
复制
发表时间:
2018-06
期刊:
影响因子:
--
通讯作者:
Anthony RV
中科院分区:
文献类型:
--
作者:
Jeckel KM;Boyarko AC;Bouma GJ;Winger QA;Anthony RV
Several developmental windows, including placentation, must be negotiated to establish and maintain pregnancy. Impaired placental function can lead to pre-eclampsia and/or intrauterine growth restriction (IUGR), resulting in increased infant mortality and morbidity. It has been hypothesized that chorionic somatomammotropin (CSH), plays a significant role in fetal development, potentially by modifying maternal and fetal metabolism. Recently, using lentiviral-mediated in vivo RNA interference in sheep, we demonstrated significant reductions in near-term (135 days of gestation; dGA) fetal and placental size, and altered fetal liver gene expression, resulting from CSH deficiency. We sought to examine the impact of CSH deficiency on fetal and placental size earlier in gestation (50 dGA), and to examine placental gene expression at 50 and 135 dGA. At 50 dGA, CSH-deficient pregnancies exhibited a 41% reduction (P≤0.05) in uterine vein concentrations of CSH, and significant (P≤0.05) reductions (≈21%) in both fetal body and liver weights. Placentae harvested at 50 and 135 dGA, exhibited reductions in IGF1 and IGF2 mRNA concentrations, along with reductions in SLC2A1 and SLC2A3 mRNA. By contrast, mRNA concentrations for various members of the System A, System L and System y+ amino acid transporter families were not significantly impacted. The IUGR observed at the end of the first-third of gestation, indicates that the near-term IUGR reported previously, began early in gestation, and may have in part resulted from deficits in the paracrine action of CSH within the placenta. These results provide further compelling evidence for the importance of CSH in the progression and outcome of pregnancy.